Betaliq, Inc.
PrivateLast Round
Series A
Apr 25, 2019
Total Funding Raised
$8M
Company Overview
Betaliq, Inc. is a drug discovery company that develops ophthalmic beta-blockers for the treatment of glaucoma using a water-free drug delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Betaliq, Inc. Comparables
Compare Betaliq, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ocuvex Therapeutics, Inc. | 86% | |
| Qlaris Bio | 80% | |
| Novaliq | 80% | |
Betaliq, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2019 |
Betaliq, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brookline Capital Markets | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2019
$8M round led by Brookline Capital Markets.
Betaliq, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Betaliq, Inc.'s valuation, stock price, and market status.